Get the Stockscreener App
2.14
4.89%
-0.11
Edesa Biotech Inc stock is traded at $2.14, with a volume of 18,701.
It is down -4.89% in the last 24 hours and up +5.42% over the past month.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
See More
Previous Close:
$2.25
Open:
$2.2105
24h Volume:
18,701
Relative Volume:
0.70
Market Cap:
$15.03M
Revenue:
-
Net Income/Loss:
$-7.72M
P/E Ratio:
-0.8108
EPS:
-2.6394
Net Cash Flow:
$-6.25M
1W Performance:
-10.08%
1M Performance:
+5.42%
6M Performance:
+12.34%
1Y Performance:
-59.11%
1-Day Range:
$2.0501
$2.2899
1-Week Range:
$2.0501
$2.4407
52-Week Range:
$1.55
$5.25
Edesa Biotech Inc Stock (EDSA) Company Profile
Name
Edesa Biotech Inc
Sector
Industry
Phone
(905) 475-1234
Address
100 SPY COURT, MARKHAM, ON
Compare EDSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
2.14 | 15.80M | 0 | -7.72M | -6.25M | -2.6394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Edesa Biotech Inc Stock (EDSA) Latest News
Custom watchlist performance reports with Edesa Biotech Inc.Technical Insight Guide for Safer Trades - Newser
What makes Edesa Biotech Inc. stock price move sharplyValue Investing Recommendation For Consistent Profits - jammulinksnews.com
How hedge fund analytics apply to Edesa Biotech Inc. stockOversold Stock Bounce Playbook Generator - Newser
How Edesa Biotech Inc. stock performs during market volatilityStock Portfolio Risk and Return Analysis - Newser
Will Edesa Biotech Inc. stock go up soonCapital Secure Pattern Signal Analysis Sheet - Newser
Edesa Biotech (EDSA) Expected to Announce Quarterly Earnings on Friday - Defense World
What institutional investors are buying Edesa Biotech Inc. stockDaily Trading Recommendation To Watch Now - jammulinksnews.com
Edesa Biotech Inc. Earnings Report Breakdown: What Investors Should KnowAI Short-Term Gain Forecast with Data - Newser
Is Edesa Biotech Inc. stock entering bullish territoryRisk-Managed Trade Alerts for Consistency - Newser
How sentiment analysis helps forecast Edesa Biotech Inc.Free Secure Return Focused Investment Plan - Newser
Edesa Biotech (NASDAQ:EDSA) Stock Price Down 1.7% – Time to Sell? - Defense World
Why is Edesa Biotech Inc. stock attracting strong analyst attentionBeginner Investor Tips For 2025 - jammulinksnews.com
How does Edesa Biotech Inc. compare to its industry peersInvest confidently with professional market insights - jammulinksnews.com
Should I hold or sell Edesa Biotech Inc. stock in 2025Invest confidently with professional market insights - jammulinksnews.com
Will Edesa Biotech Inc. Benefit From Sector TailwindsAI Powered High Return Stock Calls Dominate Watchlists - metal.it
What catalysts could drive Edesa Biotech Inc. stock higher in 2025Get daily updates on the hottest stocks - jammulinksnews.com
Is it the right time to buy Edesa Biotech Inc. stockDiscover hidden gems in the stock market - jammulinksnews.com
What are Edesa Biotech Inc. company’s key revenue driversCapitalize on proven trading setups - jammulinksnews.com
How strong is Edesa Biotech Inc. company’s balance sheetPowerful profit generation - jammulinksnews.com
How volatile is Edesa Biotech Inc. stock compared to the marketMaximize returns with strategic portfolio planning - jammulinksnews.com
What are the latest earnings results for Edesa Biotech Inc.Build wealth with reliable stock picks - jammulinksnews.com
What is the dividend policy of Edesa Biotech Inc. stockAccelerated earnings growth - jammulinksnews.com
What is the risk reward ratio of investing in Edesa Biotech Inc. stockSkyrocketing investment returns - jammulinksnews.com
Edesa Biotech Pursues $150M Mixed Securities Offering. - AInvest
Has Edesa Biotech Inc. Stock Ever Crashed Historical Volatility ReviewDouble Profit With Half Risk - Newser
How Resilient Is Edesa Biotech Inc. Stock During Economic DownturnsFree Stock Index Interpretation - Newser
Edesa Biotech's $150M Shelf Offering: A Strategic Launchpad for Biotech Disruption and Investor Opportunity - AInvest
What drives Edesa Biotech Inc. stock priceFree Advanced Stock Screener Access - PrintWeekIndia
Is Edesa Biotech Inc. a good long term investmentHigh-yield market plays - PrintWeekIndia
What analysts say about Edesa Biotech Inc. stockAccelerated profit realization - PrintWeekIndia
Edesa Biotech Inc. Stock Analysis and ForecastConsistent double returns - jammulinksnews.com
Edesa Biotech Inc Stock (EDSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):